GSA Capital Partners’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

GSA Capital Partners’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-33,629	Closed	-$3.44M	–	2355
2014 Q4	$3.44M	Sell	33,629 -12,688	-27%	-$1.22M	0.24%	35
2014 Q3	$4.01M	Buy	46,317 +2,310	+5%	+$205K	0.21%	85
2014 Q2	$3.97M	Buy	+44,007	New	+$3.29M	0.18%	93
2014 Q1	–	Sell	-23,566	Closed	-$1.6M	–	2032
2013 Q4	$1.6M	Sell	23,566 -8,087	-26%	-$526K	0.13%	150
2013 Q3	$1.93M	Buy	31,653 +25,934	+453%	+$1.58M	0.15%	131
2013 Q2	$290K	Buy	+5,719	New	+$331K	0.03%	890

GSA Capital Partners's COV Position: Q1 2015 in Review

GSA Capital Partners sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 33,629 shares — an estimated $3.44M sold.

GSA Capital Partners first reported a position in COV in Q2 2013 and held it in 6 quarters. The position peaked at $4.01M in Q3 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

GSA Capital Partners reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
GSA Capital Partners sold 33,629 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $3.44M.
GSA Capital Partners first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 6 quarters.
GSA Capital Partners's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $4.01M in Q3 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on GSA Capital Partners's 13F filing for Q1 2015, filed 14 May 2015.